1548 fundamentals
An in-depth look to GENSCRIPT BIOTECH CORPORATION operating, investing, and financing activities
1548 free cash flow for H2 23 is -1.32 B HKD. For 2023, 1548 free cash flow was -3.42 B HKD and operating cash flow was -2.22 B HKD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM